Integrating buprenorphine into an opioid treatment program

Tailoring care for patients with opioid use disorders

Soteri Polydorou, Stephen Ross, Peter Coleman, Laura Duncan, Nichole Roxas, Anil Thomas, Sonia Mendoza, Helena Hansen

    Research output: Contribution to journalArticle

    Abstract

    Objectives: This report identifies the institutional barriers to, and benefits of, buprenorphine maintenance treatment (BMT) integration in an established hospital-based opioid treatment program (OTP). Methods: This case study presents the authors' experiences at the clinic, hospital, and corporation levels during efforts to integrate BMT into a hospital-based OTP in New York City and a descriptive quantitative analysis of the characteristics of hospital outpatients treated with buprenorphine from 2006 to 2013 (N=735). Results: Integration of BMT into an OTP offered patients the flexibility to transition between intensive structured care and primary care or outpatient psychiatry according to need. Main barriers encountered were regulations, clinical logistics of dispensing medications, internal cost and reimbursement issues, and professional and cultural resistance. Conclusions: Buprenorphine integration offers a model for other OTPs to facilitate partnerships among primary care and mental health clinics to better serve diverse patients with varying clinical needs and with varying levels of social support.

    Original languageEnglish (US)
    Pages (from-to)295-298
    Number of pages4
    JournalPsychiatric Services
    Volume68
    Issue number3
    DOIs
    StatePublished - Mar 1 2017

    Fingerprint

    Buprenorphine
    Opioid Analgesics
    Patient Care
    Primary Health Care
    Outpatients
    Therapeutics
    Critical Care
    Social Support
    Psychiatry
    Mental Health
    Costs and Cost Analysis

    ASJC Scopus subject areas

    • Psychiatry and Mental health

    Cite this

    Polydorou, S., Ross, S., Coleman, P., Duncan, L., Roxas, N., Thomas, A., ... Hansen, H. (2017). Integrating buprenorphine into an opioid treatment program: Tailoring care for patients with opioid use disorders. Psychiatric Services, 68(3), 295-298. https://doi.org/10.1176/appi.ps.201500501

    Integrating buprenorphine into an opioid treatment program : Tailoring care for patients with opioid use disorders. / Polydorou, Soteri; Ross, Stephen; Coleman, Peter; Duncan, Laura; Roxas, Nichole; Thomas, Anil; Mendoza, Sonia; Hansen, Helena.

    In: Psychiatric Services, Vol. 68, No. 3, 01.03.2017, p. 295-298.

    Research output: Contribution to journalArticle

    Polydorou, S, Ross, S, Coleman, P, Duncan, L, Roxas, N, Thomas, A, Mendoza, S & Hansen, H 2017, 'Integrating buprenorphine into an opioid treatment program: Tailoring care for patients with opioid use disorders', Psychiatric Services, vol. 68, no. 3, pp. 295-298. https://doi.org/10.1176/appi.ps.201500501
    Polydorou, Soteri ; Ross, Stephen ; Coleman, Peter ; Duncan, Laura ; Roxas, Nichole ; Thomas, Anil ; Mendoza, Sonia ; Hansen, Helena. / Integrating buprenorphine into an opioid treatment program : Tailoring care for patients with opioid use disorders. In: Psychiatric Services. 2017 ; Vol. 68, No. 3. pp. 295-298.
    @article{396d7cf7959b4f2d8a73a40b4e0f31bc,
    title = "Integrating buprenorphine into an opioid treatment program: Tailoring care for patients with opioid use disorders",
    abstract = "Objectives: This report identifies the institutional barriers to, and benefits of, buprenorphine maintenance treatment (BMT) integration in an established hospital-based opioid treatment program (OTP). Methods: This case study presents the authors' experiences at the clinic, hospital, and corporation levels during efforts to integrate BMT into a hospital-based OTP in New York City and a descriptive quantitative analysis of the characteristics of hospital outpatients treated with buprenorphine from 2006 to 2013 (N=735). Results: Integration of BMT into an OTP offered patients the flexibility to transition between intensive structured care and primary care or outpatient psychiatry according to need. Main barriers encountered were regulations, clinical logistics of dispensing medications, internal cost and reimbursement issues, and professional and cultural resistance. Conclusions: Buprenorphine integration offers a model for other OTPs to facilitate partnerships among primary care and mental health clinics to better serve diverse patients with varying clinical needs and with varying levels of social support.",
    author = "Soteri Polydorou and Stephen Ross and Peter Coleman and Laura Duncan and Nichole Roxas and Anil Thomas and Sonia Mendoza and Helena Hansen",
    year = "2017",
    month = "3",
    day = "1",
    doi = "10.1176/appi.ps.201500501",
    language = "English (US)",
    volume = "68",
    pages = "295--298",
    journal = "Psychiatric Services",
    issn = "1075-2730",
    publisher = "American Psychiatric Association",
    number = "3",

    }

    TY - JOUR

    T1 - Integrating buprenorphine into an opioid treatment program

    T2 - Tailoring care for patients with opioid use disorders

    AU - Polydorou, Soteri

    AU - Ross, Stephen

    AU - Coleman, Peter

    AU - Duncan, Laura

    AU - Roxas, Nichole

    AU - Thomas, Anil

    AU - Mendoza, Sonia

    AU - Hansen, Helena

    PY - 2017/3/1

    Y1 - 2017/3/1

    N2 - Objectives: This report identifies the institutional barriers to, and benefits of, buprenorphine maintenance treatment (BMT) integration in an established hospital-based opioid treatment program (OTP). Methods: This case study presents the authors' experiences at the clinic, hospital, and corporation levels during efforts to integrate BMT into a hospital-based OTP in New York City and a descriptive quantitative analysis of the characteristics of hospital outpatients treated with buprenorphine from 2006 to 2013 (N=735). Results: Integration of BMT into an OTP offered patients the flexibility to transition between intensive structured care and primary care or outpatient psychiatry according to need. Main barriers encountered were regulations, clinical logistics of dispensing medications, internal cost and reimbursement issues, and professional and cultural resistance. Conclusions: Buprenorphine integration offers a model for other OTPs to facilitate partnerships among primary care and mental health clinics to better serve diverse patients with varying clinical needs and with varying levels of social support.

    AB - Objectives: This report identifies the institutional barriers to, and benefits of, buprenorphine maintenance treatment (BMT) integration in an established hospital-based opioid treatment program (OTP). Methods: This case study presents the authors' experiences at the clinic, hospital, and corporation levels during efforts to integrate BMT into a hospital-based OTP in New York City and a descriptive quantitative analysis of the characteristics of hospital outpatients treated with buprenorphine from 2006 to 2013 (N=735). Results: Integration of BMT into an OTP offered patients the flexibility to transition between intensive structured care and primary care or outpatient psychiatry according to need. Main barriers encountered were regulations, clinical logistics of dispensing medications, internal cost and reimbursement issues, and professional and cultural resistance. Conclusions: Buprenorphine integration offers a model for other OTPs to facilitate partnerships among primary care and mental health clinics to better serve diverse patients with varying clinical needs and with varying levels of social support.

    UR - http://www.scopus.com/inward/record.url?scp=85014069591&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85014069591&partnerID=8YFLogxK

    U2 - 10.1176/appi.ps.201500501

    DO - 10.1176/appi.ps.201500501

    M3 - Article

    VL - 68

    SP - 295

    EP - 298

    JO - Psychiatric Services

    JF - Psychiatric Services

    SN - 1075-2730

    IS - 3

    ER -